# Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis

> **NCT02805855** · PHASE1 · COMPLETED · sponsor: **Jacob L. Sellon, M.D.** · enrollment: 15 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Autologous Adipose-Derived Mesenchymal Stromal Cells

## Key facts

- **NCT ID:** NCT02805855
- **Lead sponsor:** Jacob L. Sellon, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-26
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-28
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02805855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02805855, "Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02805855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*